We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Diabetes Drug Could Be Re-purposed to Help End Transplant Rejection

News   Nov 22, 2017 | Original story from Queen Mary University of London (QMUL)

 
 Diabetes Drug Could Be Re-purposed to Help End Transplant Rejection
 
 
 

RELATED ARTICLES

Hunt for the Missing T-Cells in Glioblastoma Patients

News

Glioblastoma brain tumors can have an unusual effect on the body’s immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body’s defenses.

READ MORE

Medicine of the Future Against Infection and Inflammation?

News

Researchers have mapped how the body's own peptides act to reduce infection and inflammation by deactivating the toxic substances formed in the process.

READ MORE

Tdap Vaccination for Pregnant Women Does Not Increase Risk of Autism, Finds Study

News

A Kaiser Permanente study of more than 80,000 children born over a 4-year period showed that the prenatal Tdap vaccination (tetanus, diphtheria, acellular pertussis) was not associated with increased risk of autism spectrum disorder in children.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE